229
Participants
Start Date
April 30, 2008
Primary Completion Date
May 31, 2012
Study Completion Date
December 31, 2012
acetyl-L-carnitine/statin (simvastatin)
"acetyl-L-carnitine: 4 tablets of 500 mg a day~simvastatin: 10 to 20 mg/day as deemed clinically appropriate and according to tolerability"
placebo
placebo: 4 tablets of 500 mg a day simvastatin: 10 to 20 mg/day as deemed clinically appropriate and according to tolerability
"Clinical Research Center for Rare Diseases Aldo and Cele Daccò", Ranica
"Hospital Azienda Ospedaliera di Treviglio e Caravaggio Ambulatory of Diabetology", Ponte San Pietro
"Hospital Azienda Ospedaliera Ospedali Riunitidi Bergamo Unit of Diabetology", Bergamo
"Hospital Azienda Ospedaliera di Treviglio-CaravaggioUnit of Diabetology and Metabolic Diseases", Romano di Lombardia
"Hospital Azienda Ospedaliera di Treviglio-Caravaggio Unit of Diabetology and Metabolic Disease", Treviglio
Collaborators (1)
Leadiant Biosciences, Inc.
INDUSTRY
Mario Negri Institute for Pharmacological Research
OTHER